The tyrosine phosphatase inhibitor orthovanadate mimics NGF-induced neuroprotective signaling in rat hippocampal neurons

Neurochemistry International

Volumn 44, Issue 7, 2004, Pages 505-520

  Gerling, Norbert ^a   Culmsee, Carsten ^a   Klumpp, Susanne ^b   Krieglstein, Josef ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Mitogen activated protein kinase; Neuroprotection; Orthovanadate; Phosphoinositide 3 kinase; TrkA; Tyrosine phosphatase inhibition

Indexed keywords

BRAIN ENZYME; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; NEUROTROPHIN RECEPTOR; ORTHOVANADIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; STAUROSPORINE; TROPOMYOSIN RELATED KINASE A; UNCLASSIFIED DRUG; UO 126; VANADATE SODIUM; WORTMANNIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CELL PROTECTION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; ENZYME BINDING; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HIPPOCAMPUS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

EID: 0842331895     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2003.08.013     Document Type: Article

References (89)

1. Ahlemeyer B., Huehne R., Krieglstein J. Retinoic acid potentiated the protective effect of NGF against STS-induced apoptosis in cultured chick neurons by increasing the TrkA protein expression. J. Neurosci. Res. 60:2000;767-778.
2. Aoki Y., Huang Z., Thomas S.S., Bhide P.G., Huang I., Moskowitz M.A., Reeves S.A. Increased susceptibility to ischemia-induced brain damage in transgenic mice overexpressing a dominant negative form of SHP2. FASEB J. 14:2000;1965-1973.
3. Arregui C.O., Balsamo J., Lilien J. Regulation of signaling by protein-tyrosine phosphatases: potential roles in nervous system. Neurochem. Res. 25:2000;95-105.
4. Barford D. Protein phosphatases. Curr. Opin. Struct. Biol. 5:1995;728-734.
5. Barford D., Jia Z., Tonks N.K. Protein tyrosine phosphatases take off. Nat. Struct. Biol. 2:1995;1043-1053.
6. 2+ accumulation. Proc. Natl Acad. Sci. USA. 92:1995;9328-9332.
7. Barker P., Shooter E.M. Disruption of NGF binding to the low affinity neurotrophin receptor p75LNTR reduced NGF-binding to trkA on PC12 cells. Neuron. 13:1994;203-215.
8. Bui N.T., König H.G., Culmsee C., Bauerbach E., Pope M., Krieglstein J., Prehn J.H.M. p75 neurotrophin receptor is required for constitutive and NGF-induced survival signaling in PC12 cells and rat hippocampal neurons. J. Neurochem. 81:2002;594-605.
9. Chen R., Kim O., Yang J., Sato K., Eisenmann K.M., McCarthy J., Chen H., Qui Y. Regulation of Akt/PKB activation by tyrosine phosphorylation. J. Biol. Chem. 276:2001;31858-31862.
10. Cheng B., Mattson M.P. NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults. Brain Res. 640:1994;56-67.
11. Cohen P. The role of protein phosphorylation in human health and disease. Eur. J. Biochem. 268:2001;5001-5010.
12. Conus N.M., Hannan K.M., Cristiano B.E., Hemmings B., Pearson R.B. Direct identification of tyrosine 474 as a regulatory phosphorylation site for the akt protein kinase. J. Biol. Chem. 277:2002;38021-38028.
13. Crowder R.J., Freeman R.S. Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. J. Neurosci. 18:1998;2933-2943.
14. Culmsee C., Semkova I., Krieglstein J. NGF mediates the neuroprotective effect of the beta2-adrenoreceptor agonist clenbuterol in vitro and in vivo: evidence from an NGF-antisense study. Neurochem. Int. 35:1999a;47-57.
15. Culmsee C., Stumm R.K., Schaefer M.K., Weihe E., Krieglstein J. Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage. Eur. J. Pharmacol. 379:1999b;33-45.
16. Culmsee C., Gerling N., Lehmann M., Nikolova-Karakashian M., Prehn J.H.M., Mattson M.P., Krieglstein J. Nerve growth factor survival signaling in cultured hippocampal neurons is mediated through TrkA and requires the common neurotrophin receptor p75. Neuroscience. 115:2002;1089-1108.
17. Davies S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:2000;95-105.
18. Denu J.M., Lohse D.L., Vijayalakshmi J., Saper M.A., Dixon J.E. Visualization of intermediate and transition-state structures in protein-tyrosine phosphatase catalysis. Proc. Natl. Acad. Sci. USA. 93:1996;2493-2498.
19. Fantus I.G., Deragon G., Lai R., Tang S. Modulation of insulin action by vanadate: evidence of a role for phosphotyrosine phosphatase activity to alter cellular signaling. Mol. Cell. Biochem. 153:1995;103-112.
20. Figiel I., Kaczmarek L. Orthovanadate induces cell death in rat dentate gyrus primary culture. Neuroreport. 8:1997;2465-2470.
21. Fujiwara S., Watanabe T., Nagatsu T., Gohda J., Imoto M., Umezawa K. Enhancement or induction of neurite formation by a protein tyrosine phosphates inhibitor, 3,4-dephostatin, in growth factor treated PC12h cells. Biochem. Biophys. Res. Commun. 238:1997;213-217.
22. Goldfine A.B., Simonson D.C., Folli F., Patti M.E., Kahn C.R. Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies. J. Clin. Endocrinol. Metab. 80:1995;3311-3320.
23. Goldsmith B.A., Koizumi S. Transient association of the phosphotyrosine phosphatase SHP-2 with TrkA is induced by nerve growth factor. J. Neurochem. 69:1997;1014-1019.
24. Gómez N., Cohen P. Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases. Nature. 353:1991;170-173.
25. Gordon J.A. Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. Meth. Enzymol. 201:1991;477-481.
26. Greene L.A., Kaplan D.R. Early events in neurotrophin signaling via Trk and p75 receptors. Curr. Opin. Neurobiol. 5:1995;579-587.
27. Grimes C.A., Jope R.S. The multifaceted roles of glycogen synthase kinase 3ß in cellular signaling. Prog. Neurobiol. 65:2001;391-426.
28. Guo Q., Fu W., Xie J., Luo H., Sells S.F., Geddes J.W., Bondada V., Rangnekar V.M., Mattson M.P. Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease. Nat. Med. 4:1998;957-962.
29. Haj F.G., Markova B., Klaman L.D., Bohmer F.D., Neel B.G. Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatase-1B. J. Biol. Chem. 278:2003;739-744.
30. Hantzopoulos P.A., Suri C., Glass D.J., Goldfarb M.P., Yancopoulos G.D. The low affinity NGF receptor, p75, can collaborate with each of the Trks to potentiate functional responses to the neurotrophins. Neuron. 13:1994;187-201.
31. Han B.H., Holtzman D.M. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J. Neurosci. 20:2000;5775-5781.
32. Hempstead B.L., Martin-Zanca D., Kaplan D.R., Parada L.F., Chao M.V. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature. 350:1991;678-683.
33. Hindley A., Kolch W. Extracellular signal regulated kinase (ERK)/mitogen activated protein kinase (MAPK)-independent functions of Raf kinases. J. Cell. Sci. 115:2002;1575-1581.
34. Huang C., Zhang Z., Ding M., Li J., Ye J., Leonard S.S., Shen H.M., Butterworth L., Lu Y., Costa M., Rojanasakul Y., Castranova V., Vallyathan V., Shi X. Vanadate induces p53 transactivation through hydrogen peroxide and causes apoptosis. J. Biol. Chem. 275:2000;32516-32522.
35. Huyer G., Liu S., Kelly J., Moffat J., Payette P., Kennedy B., Tsaprailis G., Gresser M.J., Ramachandran C. Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J. Biol. Chem. 272:1997;843-851.
36. Jin K., Mao X.O., Zhu Y., Greenberg D.A. MEK and ERK protect hypoxic cortical neurons via phosphorylation of Bad. J. Neurochem. 80:2002;119-125.
37. Jing S., Tapley P., Barbacid M. Nerve growth factor mediates signal transduction through trk homodimer receptors. Neuron. 9:1992;1067-1079.
38. Kaplan D.R., Miller F.D. Signal transduction by the neurotrophin receptors. Curr. Opin. Cell Biol. 9:1997;213-221.
39. Kaplan D.R., Miller F.D. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10:2000;381-391.
40. Kaplan D.R., Hempstead B.L., Martin-Zanca D., Chao M.V., Parada L.F. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science. 252:1991a;554-558.
41. Kaplan D.R., Martin-Zanca D., Parada L.F. Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Nature. 350:1991b;158-160.
42. Kawano T., Fukunaga K., Takeuchi Y., Morioka M., Yano S., Hamada J.I., Ushio Y., Miyamoto E. Neuroprotective effect of sodium orthovanadate on delayed neuronal death after transient forebrain ischemia in gerbil hippocampus. J. Cereb. Blood Flow Metab. 21:2001;1268-1280.
43. Khwaja A. Akt is more than just a Bad kinase. Nature. 401:1999;33-34.
44. Klein R., Jing S.Q., Nanduri V., O'Rourke E., Barbacid M. The trk proto-oncogene encodes a receptor for nerve growth factor. Cell. 65:1991;189-197.
45. Klesse L.J., Meyers K.A., Marshall C.J., Parada L.F. Nerve growth factor induces survival and differentiation through two distinct signaling cascades in PC12 cells. Oncogene. 18:1999a;2055-2068.
46. Klesse L.J., Parada L.F. Trks: signal transduction and intracellular pathways. Micros. Res. Tech. 45:1999b;210-216.
47. Leis J.F., Kaplan N.O. An acid phosphatase in the plasma membranes of human astrocytoma showing marked specificity toward phosphotyrosine protein. Proc. Natl. Acad. Sci. USA. 79:1982;6507-6511.
48. Levi-Montalcini R. The nerve growth factor 35 years later. Science. 237:1987;1154-1162.
49. Li L., Dixon J.E. Form, function, and regulation of protein tyrosine phosphatases and their involvement in human diseases. Sem. Immunol. 12:2000;75-84.
50. Marte B.M., Downward J. PKB/Akt: connecting phosphoinositide-3-kinase to cell survival and beyond. Trends Biochem. Sci. 22:1997;355-358.
51. Martin-Zanca D., Hughes S.H., Barbacid M. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature. 319:1986;743-748.
52. Mattson M.P., Zhang Y., Bose S. Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis, and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose. Exp. Neurol. 121:1993;1-13.
53. Mattson M.P., Culmsee C., Yu Z., Camandola S. Roles of nuclear factor kappa B in neuronal survival and plasticity. J. Neurochem. 74:2000;443-456.
54. Mazzoni I.E., Said F.A., Aloyz R., Miller F.D., Kaplan D. Ras regulates sympathetic neuron survival by suppressing the p53-mediated cell death pathway. J. Neurosci. 19:1999;9716-9727.
55. Mustelin T., Feng G.S., Bottini N., Alonso A., Kholod N., Birle D., Merlo J., Huynh H. Protein tyrosine phosphatases. Front. Biosci. 7:2002;d85-d142.
56. Neel B.G., Tonks N.K. Protein tyrosine phoshatases in signal transduction. Curr. Opin. Cell Biol. 9:1997;193-204.
57. Nicole O., Ali C., Docagne F., Plawinski L., MacKenzie E.T., Vivien D., Buisson A. Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway. J. Neurosci. 21:2001;3024-3033.
58. Obermeier A., Lammers R., Wiesmueller K.H., Jung G., Schlessinger J., Ullrich A. Identification of Trk binding sites for SHC and phosphatidylinositol 3′-kinase and formation of a multimeric signaling complex. J. Biol. Chem. 268:1993;22963-22966.
59. Ozes O.N., Mayo L.D., Gustin J.A., Pfeffer S.R., Pfeffer L.M., Donner D.B. NF-kappa B activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature. 401:1999;82-85.
60. Patapoutian A., Reichardt L.F. Trk receptors: mediators of neurotrophin action. Curr. Opin. Neurobiol. 11:2001;272-280.
61. Philpott K.L., McCarthy M.J., Klippel A., Rubin L.L. Activated phosphatidylinositol 3-kinase and Akt kinase promote survival of superior cervical neurons. J. Cell. Biol. 139:1997;809-815.
62. Rodriguez-Viciana P., Warne P.H., Dhand R., Vanhaesebroeck B., Gout I., Fry M.J., Downward J. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature. 370:1994;508-509.
63. Rogers M.V., Buensuceso C., Montague F., Mahadevan L. Vanadate stimulate differentiation and neurite outgrowth in rat phaechromocyoma PC12 cells and neurite extension in human neuroblastoma SH-SY5Y cells. Neuroscience. 60:1994;479-494.
64. Romashkova J.A., Makarov S.S. NF-kappa B is a target of AKT in anti-apoptotic PDGF signaling. Nature. 401:1999;86-90.
65. Saeki M., Maeda S., Kamisaki Y. Vanadate protects human neuroblastoma SH-SY5Y cells against peroxynitrite-induced cell death. J. Cell. Biochem. 85:2002;721-727.
66. Salice V.C., Cortizo A.M., Gomez Dumm C.L., Etcheverry S.B. Tyrosine phosphoryaltion and morphological induced by four vanadium compounds on MC3T3E1 cells. Mol. Cell. Biochem. 198:1999;119-128.
67. Schlessinger J., Ullrich A. Signal transduction by receptors with tyrosine kinase activity. Cell. 61:1990;203-212.
68. Segal R.A., Bhattacharyya A., Rua L.A., Alberta J.A., Stephens R.M., Kaplan D.R., Stiles C.D. Differential utilization of Trk autophosphorylation sites. J. Biol. Chem. 271:1996;20175-20181.
69. Semkova I., Wolz P., Schilling M., Krieglstein J. Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage. Eur. J. Pharmacol. 315:1996a;19-30.
70. Semkova I., Schilling M., Henrich-Noack P., Rami A., Krieglstein J. Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF. Brain Res. 717:1996b;44-54.
71. Semkova I., Krieglstein J. Neuroprotection mediated via neurotrophic factors and induction of nerotrophic factors. Brain Res. Rev. 30:1999;176-188.
72. Sofroniew M.V., Howe C.L., Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Ann. Rev. Neurosci. 24:2001;1217-1281.
73. Soltoff S.P., Rabin S.L., Cantley L.C., Kaplan D.R. Nerve growth factor promotes the activation of phosphatidylinositol 3-kinase and its association with the trk tyrosine kinase. J. Biol. Chem. 267:1992;17472-17477.
74. Stephens R.M., Loeb D.M., Copeland T.D., Pawson T., Greene L.A., Kaplan D.R. Trk receptors use redundant signal transduction pathways involving SHC and PLC-gamma 1 to mediate NGF responses. Neuron. 12:1994;691-705.
75. Suzuki T., Hiroki A., Watanabe T., Yamashita T., Takei I., Umezawa K. Potentiation of insulin-related signal transduction by a novel protein-tyrosine phosphatase inhibitor, Et-3,4-dephostatin, on cultured 3T3-L1 adipocytes. J. Biol. Chem. 276:2001;27511-27518.
76. Swarup G., Cohen S., Garbers D.L. Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. Biochem. Biophys. Res. Commun. 107:1982;1104-1109.
77. Sweatt J.D. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J. Neurochem. 76:2001;1-10.
78. Tonks N.K., Neel B.G. Combinatorial control of the specificity of protein tyrosine phosphatases. Curr. Opin. Cell Biol. 13:2001;182-195.
79. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 61:1990;203-212.
80. Vambutas V., Kaplan D.R., Sells M.A., Chernoff J. Nerve growth factor stimulates tyrosine phosphorylation and activation of Src homology-containing protein-tyrosine phosphatase 1 in PC12 cells. J. Biol. Chem. 270:1995;25629-25633.
81. Van Vector D. Protein tyrosine phosphatases in the developing system. Curr. Opin. Cell Biol. 10:1998;174-181.
82. Verdi J.M., Birren S.J., Ibanez C.F., Persson H., Kaplan D.R., Benedetti M., Chao M.V., Anderson D.J. p75LNGFR regulates Trk signal transduction and NGF-induced neuronal differentiation in MAH cells. Neuron. 12:1994;733-745.
83. Wu Y.Y., Bradshaw R.A. Effect of nerve growth factor and fibroblast growth factor on PC12 cells: inhibition by orthovanadate. J. Cell Biol. 121:1993;409-422.
84. Wu X., Senechal K., Neshat M.S., Whang Y.E., Sawyers C.L. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide-3-kinase/Akt pathway. Proc. Natl Acad. Sci. USA. 95:1998;15587-15591.
85. Yao R., Cooper G.M. Requirement for phosphatidylinositol-3-kinase in the prevention of apoptosis by nerve growth factor. Science. 267:1995;2003-2006.
86. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
87. Zhang Y., Tatsuno T., Carney J.M., Mattson M.P. Basic FGF, NGF, and IGFs protect hippocampal and cortical neurons against iron-induced degeneration. J. Cereb. Blood Flow Metab. 13:1993;378-388.
88. Zhu Y., Culmsee C., Semkova I., Krieglstein J. Stimulation of beta2-adrenoceptors inhibits apoptosis in rat brain after transient forebrain ischemia. J. Cereb. Blood Flow Metab. 18:1998;1032-1039.
89. Zhu Y., Yang G.Y., Ahlemeyer B., Pang L., Che X.M., Culmsee C., Klumpp S., Krieglstein J. Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J. Neurosci. 22:2002;3898-3909.